Identification of a Novel GOLGB1-RET Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib.

Boku S., Fujisawa T., Kadowaki S., Satake H., Yasui H., Ohtsubo K., Shimizu Y., Otsuka T., Kuze B., Yamashita R., Shibuki T., Nakamura Y., Bando H., Yoshino T., Radovich M., Okano S.

DOI

10.1200/po-26-00237

Type

Journal article

Publication Date

2026-07-01T00:00:00+00:00

Volume

10

Addresses

Department of Clinical Oncology, Kansai Medical University Hospital, Hirakata City, Osaka, Japan.

Permalink More information Close